Oxcarbazepine Tablet, Film Coated
Product Images NDC 82804-209

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 82804-209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-209-72 (Image 01)

This text provides detailed information about Oxcarbazepine 300mg tablets, including their appearance, dosage, manufacturer, and storage instructions. It also includes the product identification number, expiration date, and other relevant details for dispensing the medication safely. Additionally, it reminds users to keep the medication out of the reach of children and includes contact information for the packaging company.*

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

This text provides results from a log-rank test with a p-value of 0.0001 for a treatment group using Oxcarbazepine. The data also includes details about the time trial from day 2 to day 11. *

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

Days from 1st dose to 1st seizure for two treatment groups - Oxcarbazepine and Placebo. This data can be used to evaluate the effectiveness of the treatments in preventing seizures within a certain time frame after the first dose.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

The given information shows the results of a log-rank test with a p-value of 0.0001. The data includes time to exit in days for a treatment group, divided into a high and low category. The table lists different time points (10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130) for each category. It seems to be part of a statistical analysis report.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

This description provides the results of a log-rank test with a p-value of 0.0001. The graph or table shows data related to time to exit in days for two treatment groups labeled as HIGH and LOW. Each numerical value from 0 to 130 has an associated measurement.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

FDA Label Image

Oxcarbazipinetabcamberlogo1 (Oxcarbazipinetabcamberlogo1)

FDA Label Image

Oxcarbazipinetabcamberlogo2 (Oxcarbazipinetabcamberlogo2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.